Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benznidazole therapeutic response assessment in chronic Chagas disease
2011-002022-41Phase 3Active
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of benznidazole in American trypanosomiasis (CD) (2 arms), sponsored by Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal. Primary endpoints: Change in parasite load from baseline and Specific immune response against Trypanosoma cruzi. Started Jul 2011; status: active.
02
Drugs
benznidazole
03
Conditions
American trypanosomiasis (CD)
Beyond the preview
Go deeper on 2011-002022-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002022-41.